This study was aimed at evaluating the in vitro and in vivo haematopoietic potential in macaque skeletal muscle cells. Biopsy samples showed the presence of CD34 þ (7.6%),
Introduction
Experiments from several laboratories have recently pointed out to the presence of haematopoietic stem cells in the murine skeletal muscle. [1] [2] [3] These cells have been shown to give rise to long-term haematopoietic repopulation in lethally irradiated recipients. 3 Transplantation experiments using purified cells suggested that the potential is restricted to the cell populations with CD45 þ phenotype, indicating the haematopoietic origin of the muscle-resident cells. [4] [5] [6] Why the murine muscle tissue harbours these cells is currently unknown. One hypothesis is the presence of a haematopoietic cell niche in the muscle tissue, which is either of post-natal or embryonic origin. Currently it is not known if a cell with both haematopoietic and myogenic potential resides in the muscle tissue, a question that would require clonal cell transplantation experiments.
Whether this haematopoietic potential is species restricted is also undetermined. To evaluate this question we have explored the haematopoietic potential of skeletal muscle in a non-human primate model by performing transplantation of mononuclear cell (MNC) populations obtained from muscle tissue with or without lentiviral marking.
Materials and methods

Primates
Adult male cynomolgus monkeys (Macaca fascicularis) and rhesus monkeys (Macaca mulatta) weighing 7±2 kg were housed at the Centre de Recherches du Service de Sante´des Arme´es (CRSSA) in an accredited animal facility in individual cages in holding rooms equipped with a reverse-filtered air barrier and conditioned to 23 1C with a relative humidity of 60%. Animals were fed with commercial primate chow supplemented with fresh fruit and were provided with tap water. Housing and experiments were approved by the French Army Ethics Committee in accordance with European rules and regulations. Biologic sample collection and animal management were carried out under general anaesthesia with ketamine (Imalgene, Myrial, Lyon, France).
Obtention of muscle cells
Muscle biopsies (n ¼ 5) were harvested under general anaesthesia. For in vitro experiments, 2-4 g of muscle tissue was typically obtained after small incision in a given muscle. Muscle harvest was performed from different sites including erector spinae, dorsal muscle and quadriceps, allowing a differential evaluation of the MNC populations obtained from different anatomical sites in terms of phenotype. For in vivo experiments, up to 40 g of muscle could be harvested in operating room conditions from both quadriceps muscles that contain the greatest level of MNC of interest.
Muscle tissue was then digested using collagenase (type 2, Worthington, Serlabo, Bonneuil, France) and trypsin (Gibco BRL Life Technologies, Cergy Pontoise, France) digestion as previously described. 2 Haematopoietic assays These were performed as previously described. 7 Briefly, BM, blood and muscle cells harvested from the same animal were plated in either methylcellulose (H4100, StemCell Technologies, Grenoble, France) in the presence of 37.5% fetal calf serum (FCS; 06100, StemCell Technologies), 12.5% bovine serum albumin (Sigma, Saint-Quentin Fallavier, France), 10 À4 M b-mercaptoethanol and cytokines including 3 IU/ml rh-Epo (Cylag, France), 100 IU/ml human interleukin-3 (IL-3), 50 ng/ml SCF (BHK cell line conditioned medium 5%), 10 ng/ml G-CSF (R&D systems, Abingdon, UK) for colony-forming units (CFU)-granulocyte macrophage (CFU-GM), burst-forming erythroid (BFU-E) and CFU-granulocyte-erythrocyte-monocytemegakaryocyte (CFU-GEMM) or a collagen-based medium (MegaCult-C, StemCell Technologies) for CFUmegakaryocyte (CFU-MK). All cultures were performed in duplicates, three cell concentrations were used for muscle Immunophenotyping MNC were immunophenotyped using monoclonal antibodies anti-CD45, -CD34, -CD90, -CD117, -CD31 (all from BD Biosciences, Le Pont de Claix, France), all described by the supplier as either specifically raised against or cross-reacting with non-human primate antigens.
Evaluation of side population cells by Hoechst staining MNC were centrifuged, pelleted and cells concentrations were adjusted to 10 6 cells per ml using PBS 1 Â (Gibco) at 37 1C containing 1% of FCS (HyClone, Perbio Science, Brebie`res, France). Hoechst 33342 (Molecular Probes, Eugene, OR, USA) was added at a final concentration of 5 mg/ml for muscle and cell suspensions were incubated at 37 1C for 90 min. To block the extrusion of Hoechst from cells, control experiments were performed using 100 mM of verapamil per 10 6 cells stained with Hoechst. After washing twice, Hoechst-stained cells were resuspended in PBS 1 Â at 4 1C containing 1% of FCS.
Dead cells were excluded based on propidium iodide staining (5 mg/ml; Sigma). Flow Cytometric analysis was performed on FACS Vantage SE (BD Biosciences). To determine side population (SP) cells percentage, acquisition was run on 10 6 cells. BM was collected from five untreated unirradiated animals to assess baseline SP values.
Transplantation protocols
Approximately 30-40 g of muscle tissue was obtained and immediately processed for enzymatic digestion using collagenase and trypsin. 2 We consistently obtained 10 6 MNCs per g of muscle tissue. In the transplantation experiments using non-transduced cells (n ¼ 2), fresh muscle cells obtained at day 1 of the transplant were digested, washed and kept overnight. On day 0, muscle cells were transplanted in recipients globally irradiated with a lethal 10 Gy 60 Co g dose the same day without any marrow support.
In the experiments using lentiviral transduction (n ¼ 2) the muscle was harvested at day À30 and digested as above. After washing, cells were then frozen in liquid nitrogen using 10% DMSO. At day À4 of transplantation, muscle cells were thawed and incubated in DMEM/F12 medium (Gibco) containing 10% FCS. At day À2, a BM harvest was obtained from the same animal under general anaesthesia to obtain a haematopoietic support containing 2 Â 10 6 CD34 þ cells per kg. At day À1, the animals received 6 Gy TBI and at day 0 they were transplanted with both lentivirally marked green fluorescent protein (GFP) þ muscle cells and the haematopoietic graft.
Lentiviral supernatant production
Lentiviral supernatants used in this study were obtained using the lentiviral vector expressing the GFP: pRRL-CPPT-PGK-WPRE, kindly provided by L Naldini (Laboratory for Gene Transfer and Therapy, University of Torino, Italy).
The production of viral supernatants was performed by transient transfection of HEK293T cells using three plasmids: an encapsidation plasmid (pCMV 8.74), a vesicular stomatitis virus envelope expression plasmid (pMD2G) and the woodchuck post-transcriptional regulatory element (WPRE) plasmid vector. This transfection was performed in the presence of Exgen 500 (Euromedex, Souffelweyersheim, France). Lentiviral supernatants were harvested and concentrated by ultracentrifugation leading to titres ranging from 10 8 to 5 Â 10 8 when assayed on NIH 3T3 murine fibroblasts.
Lentiviral transduction protocol of the muscle cells
Previously frozen muscle cells were thawed and put in culture in DMEM/F12 medium containing 10% FCS. After 48 h, the medium was removed and the lentiviral supernatant with a titre of 10 7 /ml was added to the adherent cell population with a calculated multiplicity of infection of 10-15, in the presence of polybrene (2 mg/ml). At day þ 1, both adherent and non-adherent cells were removed, washed three times and maintained in culture for 24 h. At day þ 2, both adherent and non-adherent cells were removed, washed and used for transplantation experiments. A small aliquot of cells was maintained in culture to evaluate the GFP positivity 24 h later.
Follow-up of the transplanted animals
Cynomolgus monkeys transplanted without lentivirally marked cells were followed in the CRSSA facility (Grenoble) whereas two rhesus monkeys transplanted with lentivirally marked cells were followed in the BSL 3 facility of the Commissariat a`l'Energie Atomique, Fontenay-auxRoses (CEA). In both centres, they were assessed regularly with clinical evaluation and complete blood count (CBC) and underwent irradiated blood transfusions as required. In two animals that received lentivirally marked cells, GFP þ cells were evaluated in BM and BM-derived colonies from 3 weeks up to 6 months after transplantation (BM samples were obtained on the third week after transplantation, then every 2 weeks up to 2 months and then every month up to 6 months; regarding clonogenic assays, 10 colonies per time were picked up, pooled and analysed for GFP positivity).
PCR experiments to detect GFP þ cells DNA was extracted from peripheral blood and marrow samples obtained from two macaques. Pooled clonogenic cells obtained from methylcellulose assays were also used for PCR analysis. PCR was performed using GFP primers and a nested PCR protocol. The external GFP primers were: GFP ext1: 5 0 -CACCATCTTCTTCAAGGACGAC 3 0 and GFP ext2: 5 0 -GATGTTGTGGCGGATCTTGA 3 0 . GFP internal primers were: GFP int1 5 0 -ACGACGG CAACTACAAGACC 3 0 and GFP int2 5 0 -ATCTT GAAGTTCACCTTGATGCC 3 0 . A total of 40 cycles of PCR were performed using a denaturation (95 1C, 30 s), annealing (60 1C, 30 s) and extension (72 1C, 30 s) followed by a final extension of 10 min. 5 ml of the first PCR product was used to start the second amplification with internal primers. Amplification of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was performed as control for DNA integrity and GFP-expressing Ba/F3 cell DNA was used as positive controls. The amplified fragments were visualized in agarose gels after electrophoresis.
Results
Evaluation of haematopoietic and stem cell markers in skeletal muscle from cynomolgus macaques Table 1 shows the averaged results of haematopoietic markers found in either fresh or thawed muscle cells before or after transduction from quadriceps biopsies of macaques 55203 and 56123. Flow cytometric dot plots of muscle MNC from a representative monkey are shown in Figure 1 assessing the expression of CD45, CD34, CD90 and SP phenotype. As indicated in Table 1 , the percentage of CD45 þ cells in macaque muscle cells was very low (0.8% in fresh cells, 0.3% in frozen cells). On the other hand, macaque muscle contained high levels of CD34 þ cells (7-12%). Muscle cells had low levels of CD31 þ cells (1.5% in fresh cells) and high levels of CD90 þ cells (8-9%). Macaque muscle contained high levels of SP cells (7-10% of MNC fraction) but no CD45 positivity was found in the SP cell fraction. Thus, cryopreservation did not appear to significantly modify the phenotypic profile of muscle cells.
In vitro evaluation of haematopoietic potential Clonogenic tests were performed using fresh muscle MNC fraction as well as SP fraction obtained from muscle using standard human methylcellulose containing Epo, IL-3, G-CSF and SCF. In five experiments no evidence of clonogenic cells were found in the muscle MNC fraction whereas marrow MNC, and to a lesser extent blood MNC, assayed in the same conditions gave rise to a significant clonogenic activity as shown in Figure 2 .
SP cells were also tested in terms of their long-term culture-initiating cell (LTC-IC)-generating potential using irradiated human mesenchymal cells stroma and a combination of cytokines including SCF, TPO, Flt3-ligand and IL-3. Cultures were evaluated by visual inspection weekly and at week þ 5, they were trypsinized and a clonogenic assay was performed using both adherent and nonadherent layers. In several experiments no evidence of LTC-IC-derived clonogenic activity was found. Table 2 summarizes the results of four transplantation experiments. To determine if the muscle graft would rescue the animals from lethal irradiation, two cynomolgus monkeys (3703 and G949) were transplanted with total muscle MNC after a myeloablative 10 Gy TBI on day À1. The numbers of MNC infused were 26 Â 10 6 (3703) and 9.5 Â 10 6 (G949). Haematological (CBC) and clinical monitoring was performed in both macaques. Both animals had profound aplasia and required RBC transfusion. Haematopoietic reconstitution did not occur and both animals died respectively at 11 and 16 days, from diffuse bleeding and cerebral thrombosis.
Muscle transplantation experiments
Two rhesus monkeys (55203 and 56123) were transplanted using lentivirally transduced GFP þ (84 and 25%, respectively) muscle cells. At day À1, they received a sublethal 6 Gy TBI and at day 0, they were transplanted with both lentivirally marked GFP þ muscle cells and a haematopoietic graft containing 2 Â 10 6 CD34 þ cells per kg. The animal 56123 received half of the transplant by i.v. injection (19 Â 10 6 MNC) whereas the remaining half was injected in the humeral marrow under general anaesthesia. Thus, macaques 55203 and 56123 received respectively 0.8 Â 10 6 /kg and 0.63 Â 10 6 /kg CD34 þ muscle cells as shown in Table 2 . After transplantation, they were monitored weekly using CBC and after recovering from aplasia, by marrow aspirates to determine the presence of GFP þ haematopoietic colonies. Haematopoietic reconstitution occurred in both animals but no evidence of GFP þ cells was found in flow cytometry at either early or late time points up to 6 months. No GFP þ haematopoietic colonies were found in methylcellulose.
We sought to determine by PCR analyses if rare GFP þ cells could be detected in peripheral blood, marrow or in clonogenic cells obtained from methylcellulose cultures. Each DNA sample was analysed using GFP-specific primers and the same sample was amplified using GAPDH primers. In macaque 56123, marrow and PBMNC samples obtained at day þ 19 were negative for GFP sequences. Similarly, DNA samples obtained from methylcellulose cultures at different time points (days þ 13, þ 28 and þ 35)
were negative. On the other hand, in macaque 55203, DNA from BM obtained at day þ 41 was found to be positive for GFP sequences after PCR amplification using internal primers, as shown in Figure 3 , but GFP positivity could not be detected in the pooled colonies originating from methylcellulose assays performed with the day þ 41 BM sample. Methylcellulose assays performed at days þ 27 and þ 55 were also negative for GFP sequences.
Discussion
The goal of this work was to evaluate the presence of a haematopoietic potential in the macaque muscle using in vitro and in vivo assays. Data from the literature suggest that murine muscle contains stem cells with haematopoietic potential capable of generating myelo-lymphoid progeny and reconstituting haematopoiesis in three generations of lethally irradiated recipients. 2, 3 However, in macaque muscle several phenotypic differences were noted. First, as opposed to murine muscle, macaque muscle contained very low levels of CD45 þ cells (0.8%). Second, the percentage of SP cells was found to be unusually high (7-10%) as compared to murine muscle in which this percentage does not exceed 1%. 1, 8 From the functional point of view, we have not been able to generate any haematopoietic activity using clonogenic tests from MNC fraction and LTC-IC assays from SP fraction. This point is also a significant difference from murine muscle in which we were able to quantitate SP-cell-derived clonogenic progeny and LTC-IC-derived progeny. 9 In in vivo experiments, transplantation of muscle MNC fraction did not induce any rescue from radiation-induced aplasia. To circumvent aplasia-related mortality and to track the fate of transplanted muscle cells, we used lentiviral GFP-transduced muscle cells that were transplanted in the presence of a haematopoietic graft. Two animals transplanted this way were followed by the expression of GFP in their peripheral blood and clonogenic cells from BM aspirates. There was no evidence that GFP þ cells were identified by flow cytometry. Similarly, in clonogenic assays we did not find any colony-expressing GFP marker. In one macaque, a transient GFP positivity could be obtained by PCR in the marrow DNA obtained at 41 days after transplantation.
Several hypotheses could explain these results. The haematopoietic potential found in the muscle could be species restricted. In favour of this hypothesis is the fact that using a similar gene-marking experiment, Gao et al. 10 were not able to identify a significant haematopoietic regeneration after transplantation of monkey muscle cells. However, some studies have reported human and nonhuman primate muscle tissues to be the site of a haematopoietic potential [11] [12] [13] whereas a recent study demonstrated a negligible haematopoietic potential in adult human skeletal muscle. 14 Another possibility to explain the lack of efficiency of macaque muscle cells in terms of haematopoietic potential is the low level of CD45 þ cells, but data documenting the generation of haematopoietic cells from CD45 À cells have been reported. 15 In our experiments, the freezing and culture procedure used for lentiviral gene marking could have led to the elimination of the cells with haematopoietic potential. Finally, the hypothesis of downregulation of GFP expression in transplanted cells appears unlikely as the PCR experiments to detect GFP DNA in the post transplant samples appeared to be positive in one sample of marrow DNA collected at day þ 41 in the animal 55203 that received the GFP þ cells by i.v. injection. This signal may not derive from a haematopoietic progenitor as the DNA extracted from a pool of marrow clonogenic cells obtained the same day was negative. Moreover, the relative /kg for macaque 56123) are not likely to constitute a situation where haematopoietic grafts would outcompete muscle cell grafts. In fact, the respective contributions of BM cells and muscle-derived cells to haematopoietic recovery should be interpreted with caution since BM CD34 þ cells are CD45 þ whereas muscle CD34 þ cells do not initially express CD45 antigen. Overall, our experiments strongly suggest that in the conditions reported in this work, primate muscle tissue, either as fresh cell population or after gene marking, could not generate haematopoietic potential after transplantation.
